NCT06167538

Brief Summary

After severe acquired brain injury (SABI: severe traumatic brain injury, stroke, anoxic brain damage), up to 50-70% of patients are tracheostomized. The need to tracheostomize a patient is based on the prolonged inability to breathe and/or protect their airway sufficiently. This is usually done in an Intensive Care Unit (ICU). A tracheostomy is first removed when the patient's clinical conditions allow for it. The removal can be performed in many settings, a neurological rehabilitation unit being one of these. The overall objective of this study is to evaluate the safety of this earlier decannulation procedure in patients with SABI at our department as well as the effectiveness on functional ability.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 12, 2023

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

December 12, 2023

Status Verified

December 1, 2023

Enrollment Period

6 months

First QC Date

November 17, 2023

Last Update Submit

December 11, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mortality at three months after hospital discharge

    Rate of survival

    Three months counted from hospital discharge

  • Mortality at twelve months after hospital discharge

    Rate of survival

    Twelve months counted from hospital discharge

Secondary Outcomes (4)

  • Rate of antibiotics prescribed to treat pneumonia after decannulation

    Counted number of days from decannulation until discharge

  • Rate of re-cannulation of the tracheal tube after initial decannulation

    Counted number of days from decannulation until discharge

  • Length of hospital stay

    Counted number of days from admission to our department until discharge

  • Rate of hospital readmission at two and twelve months after discharge

    At two and twelve months respectively counted from discharge

Study Arms (2)

SABI patients with a tracheal tube treated with the new decannulation procedure.

All adult SABI patients ≥ 18 years with a tracheal tube at admission to the Department of Brain Injury from September 2021 to October 2022 and treated with the new decannulation procedure.

Other: Decannulation

SABI patients in whom decannulation was attempted before implementation of the new procedure.

Patients with SABI and a tracheal tube in whom decannulation was attempted between July 2019 until December 2020 will serve as a historical control group.

Other: Decannulation

Interventions

From the 1st of September 2021, the investigators started to perform decannulation earlier after admission to the Department of Brain Injury. Before attempting to decannulate a patient, several factors were considered and assessed by the patient's treating team: patient's level of consciousness, hemodynamical stability, need for and frequency of salivary aspiration, cough strength and respiration frequency. Patients could not be under treatment for pneumonia and simultaneously have respiratory instability at the time of decannulation.

SABI patients in whom decannulation was attempted before implementation of the new procedure.SABI patients with a tracheal tube treated with the new decannulation procedure.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult SABI patients ≥ 18 years with a tracheal tube at admission to the Department of Brain Injury from September 2021 to October 2022 and treated with the new decannulation procedure will be included. Patients with SABI and a tracheal tube in whom decannulation was attempted between July 2019 until December 2020 will serve as a historical control group.

You may qualify if:

  • All severe acquired brain injury patients ≥ 18 years with a tracheal tube at admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Brain Injury, Rigshospitalet

Glostrup Municipality, 2600, Denmark

Location

MeSH Terms

Conditions

Brain Injuries

Interventions

Tracheostomy Decannulation

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

TracheostomyAirway ManagementTherapeuticsDevice RemovalSurgical Procedures, OperativeOstomyOtorhinolaryngologic Surgical ProceduresThoracic Surgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Head, MD, PhD

Study Record Dates

First Submitted

November 17, 2023

First Posted

December 12, 2023

Study Start

July 1, 2023

Primary Completion

January 1, 2024

Study Completion

April 1, 2024

Last Updated

December 12, 2023

Record last verified: 2023-12

Locations